Bovine Rotavirus A

Overview and Taxonomy of Bovine Rotavirus A

Bovine Rotavirus A (BRVA) represents a significant etiological agent of neonatal calf diarrhea, exerting a profound economic burden on the global cattle industry. This virus is the primary viral cause of gastroenteritis in calves, leading to morbidity, mortality, and substantial losses in both dairy and beef production systems worldwide [1, 2, 7, 9]. As a member of the Reoviridae family, genus Rotavirus, BRVA is a non-enveloped virus characterized by a distinctive double-stranded RNA (dsRNA) genome composed of 11 segments, each encoding either a structural (VP1-VP4, VP6, VP7) or a non-structural (NSP1-NSP5/6) protein [1, 4, 13, 29]. The World Organisation for Animal Health (WOAH) and the Food and Agriculture Organization (FAO) recognize rotavirus infections as a critical concern for livestock health, particularly in the context of intensifying agricultural practices. Similarly, the zoonotic potential of certain strains, frequently underscored by the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC), elevates BRVA beyond a purely veterinary concern into a domain of public health significance, highlighting the need for continuous molecular surveillance.

Taxonomic Classification and Genomic Architecture

Within the Rotavirus genus, classification is historically based on the antigenicity of the inner capsid protein VP6, which defines eight distinct serogroups (A through H) [4, 17]. Group A rotaviruses, including BRVA, are the most prevalent and clinically relevant in both human and animal populations [1, 4, 18]. The vast majority of bovine rotavirus strains causing significant disease in calves belong to this serogroup, while other groups such as B and C are detected far less frequently and with minimal clinical impact in cattle [4]. The 11-segmented genome of BRVA is a cornerstone of its evolutionary plasticity. This segmented nature permits genetic reassortment during co-infection of a single host with multiple rotavirus strains, a phenomenon that drives the emergence of novel genotypes and has profound implications for vaccine efficacy and interspecies transmission [1, 12, 21, 25].

A universally adopted classification system for rotaviruses, including BRVA, is the dual genotyping system based on the two outer capsid proteins: the glycoprotein VP7 (defining G genotypes) and the protease-sensitive spike protein VP4 (defining P genotypes) [2, 6, 10, 19]. This system is analogous to the serological typing used for other viruses and is fundamental to understanding the epidemiological dynamics of BRVA at both national and global levels [2, 26]. To date, extensive molecular surveys have identified a limited but evolving set of common G and P genotypes circulating in global bovine populations. The most frequently encountered G genotypes are G6, G10, and to a lesser extent G8, with sporadic reports of G3 and G11 [6, 18, 22, 24, 26]. For P genotypes, the predominant types are P[1], P[5], and P[11] [1-3, 15, 19, 20]. These genotypes form the basis for the most common G/P combinations observed globally, particularly G6P[1], G6P[5], G6P[11], and G10P[11], the epidemiological distribution of which varies significantly by geographic region and production system [2, 10, 19, 22, 26].

Phylogenetic Diversity and Molecular Epidemiology of Predominant Genotypes

The global landscape of BRVA is characterized by remarkable genetic heterogeneity within these predominant genotypes, a point of immense importance for vaccine design and disease control. Phylogenetic analyses of the VP7 and VP4 genes have revealed that each major genotype can be subdivided into distinct lineages, often with differential geographic and host species associations [22, 26].

G6 Genotype Diversity: The G6 genotype is undeniably the most prevalent globally, but it is not a monolith. Phylogenetic analyses consistently identify multiple lineages within G6, most notably lineages III, IV, V, and VI [3, 18, 22, 26]. Lineage IV is frequently associated with G6P[5] strains, particularly dominant in beef herds in Argentina and also circulating in Spain and Ireland [18, 19, 22, 26]. In contrast, G6 lineage III is more often associated with P[11] genotypes and has been found in both dairy and beef settings [22, 26]. A newer lineage, G6 lineage VI, was recently identified in dairy calves and yaks in China, indicating the ongoing evolution and emergence of novel clusters [3]. This lineage-level diversity has significant implications, as strains circulating in the field may be antigenically distinct from vaccine strains belonging to a different G6 lineage, potentially contributing to vaccine failure [15, 20].

G10 Genotype Diversity: While less genetically diverse than G6, the G10 genotype is also a major player in bovine rotavirus ecology. G10 strains are most frequently found in combination with P[11] (G10P[11]) and are particularly prevalent in dairy herds [2, 15, 22, 26, 30]. G10P[11] is a common genotype in Japan, Bangladesh, and parts of South America [2, 10, 22]. The VP8* domain of the G10P[11] strain has been a subject of intense study, revealing a unique glycan-binding specificity that allows it to recognize precursor glycans abundant in the neonatal gut, a feature critical for its age-restricted tropism and its capacity for zoonotic transmission to human neonates [27].

P Genotype Dynamics: The P genotype, particularly P[1], P[5], and P[11], shows strong associations with specific G genotypes and production systems. P[1] is frequently linked with G6 and is the dominant P type in many Chinese strains, including those from yaks and dairy calves [1, 3]. P[5] is often associated with G6 lineage IV strains (e.g., the G6P[5] WC3 strain used in the human RotaTeq vaccine) and is highly prevalent in beef herds in Argentina and elsewhere [14, 20, 22, 26]. P[11] is almost exclusively found with G6 (lineage III) or G10, and is a hallmark of dairy herds [22, 26]. Interestingly, mixed P-type infections, where a single sample contains viruses with multiple P genotypes (e.g., P[1], P[5], P[11]), have been reported at high frequencies, particularly in Brazil, indicating a fertile environment for reassortment [24, 30]. The detection of human-like P genotypes (P[4], P[6]) in bovine samples further underscores the potential for complex, cross-species evolutionary dynamics [30].

Reassortment and the Interface with Human Health

One of the most evolutionarily and epidemiologically significant aspects of BRVA is its role as a donor of genetic material in the emergence of novel human rotavirus strains. The segmented genome of the virus allows for extensive reassortment, and BRVA strains have been repeatedly implicated in the genesis of bovine-human reassortant viruses [12, 21, 23, 28, 31]. Whole-genome analyses have revealed that numerous human strains possess a “bovine-like” genetic backbone, particularly for the genes encoding structural proteins like VP1, VP2, VP3, VP6, and the NSP2 and NSP4 proteins [23, 31].

The emergence of DS-1-like intergenogroup reassortant strains, such as G8P[8], highlights the critical role of BRVA in this process. These strains, first identified in Southeast Asia and now circulating in Europe, possess a mixture of human (e.g., P[8]) and bovine-derived (e.g., G8, I2, R2, C2, M2, A3) genetic segments [12, 21]. Similarly, human G6P[13] and G10P[13] strains have been isolated from children with severe diarrhea, and their genomes are predominantly of artiodactyl (bovine) origin, providing direct evidence for independent, multi-lineage zoonotic transmission events [16, 23]. The detection of bovine-like genes in human strains in Africa, such as the G8P[6] strains from Ghana, and in Korean G3P[9] strains (with feline and bovine contributions), illustrates the global nature of this dynamic and the intricate pathways of rotavirus evolution [28, 31].

This continuous flow of genetic information between bovine and human rotaviruses is a powerful driver of viral diversity and a significant challenge for public health. It underscores the necessity for integrated surveillance systems that monitor rotaviruses in both human and animal populations. Understanding the complex taxonomy and phylogeny of BRVA, therefore, is not merely an academic exercise; it is a fundamental prerequisite for designing effective vaccines, predicting the emergence of pandemic-potential strains, and implementing robust control strategies in line with the One Health approach advocated by the WHO, WOAH, and FAO.

Molecular Pathogenesis of Bovine Rotavirus A

Attachment, Entry, and Cellular Tropism

The pathogenesis of Bovine Rotavirus A (BRVA) begins with intricate molecular interactions at the host cell surface, a process that dictates host range, tissue tropism, and the severity of enteric disease. The viral outer capsid, composed of VP7 and the VP4 spike protein, orchestrates initial attachment and entry into mature enterocytes lining the small intestinal villi. The VP4 protein is proteolytically cleaved into VP8* and VP5* domains, with VP8* serving as the primary receptor-binding domain. Critically, BRVA strains exhibit genotype-dependent glycan recognition, which underpins species specificity and zoonotic potential. Studies on the WC3 G6P[5] strain and its mono-reassortant G4P[5] RotaTeq vaccine derivative have demonstrated a unique dual recognition mechanism, binding both α2,6-linked sialic acid (SA) and the αGal histo-blood group antigen (HBGA) [14]. This is a remarkable departure from the earlier paradigm that bovine rotaviruses solely utilize sialic acids. The absence of both α2,6-linked SA and αGal HBGA on human small intestinal epithelial cells explains the lack of natural human infection by P[5]-bearing strains, yet these strains can still infect human intestinal cells via alternative receptors such as integrins, hsp70, and tight-junction proteins bound by the VP5* domain [14].

Further structural studies on neonate-specific G10P[11] bovine-human reassortant strains have revealed the structural basis for age-restricted tropism. The VP8* domain of these strains possesses a distinct glycan-binding site that uniquely recognizes either type I or type II precursor glycans [27]. These precursor glycans are developmentally regulated in the neonatal gut and are abundant in bovine and human milk, providing a molecular explanation for why rotavirus disease is predominantly observed in young calves during the first weeks of life [27]. This age-dependent expression of specific glycans represents a critical determinant of susceptibility and directly correlates with the epidemiological observation that BRVA infection rates peak in calves under one month of age, with the odds of infection being 3.1 times higher in calves aged ≤5 weeks compared to older animals [10].

Following attachment, viral entry requires cellular cholesterol and functional lipid rafts. Cholesterol depletion of the plasma membrane using methyl-β-cyclodextrin (MβCD) has no effect on BRV binding to cells but significantly impairs viral entry in a dose-dependent manner, an effect that is partially reversed by exogenous cholesterol [33]. Notably, cholesterol depletion after viral entry does not reduce replication but does affect virus assembly, indicating that cholesterol-rich membrane microdomains are essential at multiple stages of the BRV life cycle, from entry through to morphogenesis [33].

Replication, Gene Constellation, and Pathogenic Determinants

Upon entry, the double-layered particle (DLP) is released into the cytoplasm, where the 11 segments of double-stranded RNA (dsRNA) serve as templates for transcription. The inner capsid protein VP6, which forms the middle layer of the virion, is highly immunogenic and serves as the group-specific antigen defining group A rotaviruses [5]. The VP6 gene is highly conserved, enabling the development of robust diagnostic tools such as indirect ELISA methods that detect anti-VP6 antibodies with high sensitivity and specificity [5]. This conservation also makes VP6 a reliable target for molecular detection, including gold nanoparticle-assisted PCR assays that can achieve detection limits as low as 9.40 × 10² copies/μL [13].

The segmented nature of the rotavirus genome is a fundamental driver of BRVA pathogenesis and evolution. Reassortment, the swapping of gene segments during co-infection, generates novel strains with altered virulence, antigenicity, and host range. Whole-genome analyses have revealed that BRVA strains possess distinctive genotype constellations. The reference strain QH-1, isolated from yak in China, exhibits the constellation G6-P[1]-I2-R2-C2-M2-A3-N3-T6-E2-H3, identified as a reassortment product involving bovine, human, and ovine rotavirus strains [1]. Such interspecies reassortment is not a rare event; it is a continuous process documented across multiple continents. In Thailand, novel DS-1-like G8P[8] strains emerged through multiple reassortment events between bovine and human rotavirus gene segments, with the 2013 strains carrying VP7, VP6, VP1, and NSP2 genes of bovine origin, while the 2014 strains had undergone additional reassortment with locally circulating human DS-1-like G2P[4] strains [21]. This dynamic genomic plasticity means that BRVA cannot be considered a static pathogen; it is a constantly evolving viral quasispecies capable of generating unpredictable gene combinations.

The specific genotype constellation directly influences pathogenic potential. Studies in Argentina revealed a distinct association between exploitation type and genotype distribution: G6(IV)P[5] was predominant in beef herds (58% prevalence), whereas dairy herds exhibited a more even distribution of G6(III)P[11] (15%), G10P[11] (17%), and G6(IV)P[5] (14%), with a high percentage of co-infections and co-circulation (20% in beef, 23% in dairy) creating a fertile environment for reassortment [26]. The P[5] genotype is associated with homotypic immunity, meaning that vaccination against one P genotype may not confer protection against heterologous P types [20]. This has profound implications for vaccine strategy, as outbreaks of G6P[5] strains have occurred in herds vaccinated with G6P[1] and G10P[11] vaccines, directly demonstrating the failure of heterotypic protection [20].

Host Cell Damage and Intestinal Pathology

The molecular pathogenesis of BRVA culminates in profound destruction of the intestinal epithelium. Infection of mature absorptive enterocytes at the tips of villi leads to cell death, denudation, and villus atrophy. Immunohistochemical analysis of naturally infected calves has demonstrated that BRVA antigen is prominently distributed within the lining epithelium of villi and Peyer's patches in the ileum, with strong immunoreactions observed in lymphocytes and macrophages of the mesenteric lymph nodes [32]. Histopathologically, infected calves exhibit characteristic lesions including shortening and fusion of villi, denudation of the epithelial surface, and infiltration of mononuclear cells in the lamina propria [32, 34]. These architectural changes result in a dramatic reduction in the absorptive surface area of the small intestine, leading to malabsorptive diarrhea.

The diarrhea produced is further compounded by the action of the non-structural protein NSP4, which functions as a viral enterotoxin. NSP4 mobilizes intracellular calcium, disrupts tight junctions, and stimulates chloride secretion from crypt cells, contributing to the secretory component of rotavirus diarrhea. The net effect is a severe, dehydrating gastroenteritis that can be fatal in neonatal calves, with mortality rates reaching 12% during outbreaks [34]. The World Organisation for Animal Health (WOAH) recognizes BRVA as a major cause of economic losses in the global cattle industry, with the Food and Agriculture Organization (FAO) highlighting its impact on livestock productivity in developing nations.

Disruption of the Gut Microbiota and Dysbiosis

Beyond direct viral cytopathology, BRVA infection induces profound alterations in the intestinal microbiota that contribute to disease pathogenesis. Metataxonomic analysis of fecal samples from rotavirus-infected calves reveals a significant decrease in bacterial diversity compared to healthy controls [8]. Alpha diversity metrics, including evenness and Shannon indices, trend toward reduction as early as one day post-inoculation, while beta diversity (Bray-Curtis dissimilarity) shows distinct clustering between infected and healthy groups [8]. This dysbiosis is characterized by a marked increase in potentially pathogenic taxa such as Enterococcus, Streptococcus, and Escherichia-Shigella, accompanied by a reduction in beneficial bacteria that contribute to short-chain fatty acid (SCFA) production, including Alistipes, Faecalibacterium, Pseudoflavonifractor, Subdoligranulum, Alloprevotella, Butyricicoccus, and Ruminococcus [8].

The loss of SCFA-producing bacteria is particularly significant, as these metabolites play critical roles in maintaining colonic health, providing energy for colonocytes, and modulating immune responses. The shift in microbial composition also involves an increase in Proteobacteria at the phylum level and Enterobacteriales at the order level, with a corresponding decrease in Firmicutes and Oscillospirales [35]. This microbial signature is indicative of a pro-inflammatory environment that may exacerbate intestinal damage and prolong diarrhea. Critically, probiotic intervention using Limosilactobacillus fermentum has been shown to partially reverse this dysbiosis, restoring Firmicutes abundance and improving alpha diversity indices, suggesting that modulation of the gut microbiota represents a viable adjunctive therapeutic strategy [35].

Zoonotic Potential and Public Health Implications

The molecular pathogenesis of BRVA extends beyond veterinary medicine into the realm of public health, as the virus exhibits significant zoonotic potential. The Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO) have recognized that group A rotaviruses are capable of crossing species barriers, with bovine rotaviruses serving as a reservoir for novel human strains. Whole-genome analysis has repeatedly demonstrated that many human rotavirus strains carry gene segments of bovine origin. A G10P[13] strain isolated from a child with acute gastroenteritis in Thailand possessed an entire artiodactyl (likely bovine) genetic backbone, with all 11 gene segments clustering with bovine rotavirus sequences [16]. Similarly, a human G6P[13] strain from Thailand (SKT-27) had nine of its 11 genes of bovine origin, with only VP1 and NSP2 derived from human strains, indicating a zoonotic transmission event followed by reassortment [23].

The detection of human G and P genotypes in bovine samples further underscores the bidirectional nature of rotavirus transmission. In Brazil, bovine samples were found to carry human genotypes P[4] and P[6], providing direct evidence of interspecies transmission and the potential for the emergence of novel reassortant strains with unpredictable pathogenic properties [30]. The emergence and rapid spread of DS-1-like intergenogroup reassortant strains bearing bovine-origin gene segments in Asia, Australia, and Europe [21], along with the detection of G8P[8] strains in the Czech Republic [12] and Ghana [28], demonstrates that these events are not isolated incidents but rather a continuous global phenomenon. The presence of bovine rotavirus gene segments in human vaccine strains, such as the G6P[5] backbone of the RotaTeq vaccine and the 116E human-bovine natural reassortant [36, 37], while beneficial for vaccine development, also highlights the close evolutionary relationships between bovine and human rotaviruses.

The molecular basis for this zoonotic potential lies in the plasticity of the VP8* receptor-binding domain. While many bovine strains show a preference for sialic acid receptors not abundantly expressed on human enterocytes, the dual recognition of αGal HBGA and sialic acid by P[5] strains, coupled with the ability to utilize alternative receptors via VP5*, provides a mechanism for cross-species infection [14]. Furthermore, the finding that bovine G6 and G10 strains cluster phylogenetically with human strains in multiple lineages [22] suggests that the genetic barriers between species are porous and that sustained surveillance is essential for pandemic preparedness. The WHO has emphasized that integrated human-animal rotavirus surveillance is critical for monitoring the emergence of novel strains with pandemic potential.

Global and Regional Epidemiology of Bovine Rotavirus A

Bovine Rotavirus A (BRVA) represents one of the most significant etiological agents of neonatal calf diarrhea worldwide, imposing substantial economic burdens on the cattle industry through mortality, morbidity, reduced weight gain, and increased veterinary care costs. The epidemiological landscape of BRVA is characterized by remarkable genetic diversity, complex transmission dynamics, and a continually evolving distribution of genotypes across different geographical regions and production systems. Understanding the global and regional epidemiology of BRVA is not merely an academic exercise but a critical prerequisite for the development of effective vaccination strategies, biosecurity protocols, and public health interventions, particularly given the documented zoonotic potential of bovine rotavirus strains.

Global Prevalence and Burden of Disease

The global burden of BRVA-associated neonatal calf diarrhea is substantial, with prevalence estimates varying considerably depending on diagnostic methodologies, sampling strategies, geographical location, and management practices. A comprehensive meta-analysis of worldwide neonatal calf diarrhea caused by bovine rotavirus in combination with other enteropathogens revealed that BRV-Cryptosporidium spp. mixed infections exhibited the highest mean pooled prevalence at 6.69% (confidence interval [CI]: 4.27–9.51), followed by BRV-bovine coronavirus (BCoV) at 2.84% (CI: 1.78–4.08) and BRV-Escherichia coli K99 (ETEC) at 1.64% (CI: 0.76–2.75) [7]. These data underscore the frequent polymicrobial nature of neonatal calf diarrhea and highlight the importance of considering co-infections in epidemiological studies and clinical management. The same meta-analysis, encompassing 41 studies across 21 countries, demonstrated that the odds of detecting BCoV in diarrheic calves were 1.83 times higher in the presence of BRV compared to calves without BRV, suggesting potential synergistic interactions between these viral pathogens [7]. Conversely, an inhibition effect (odds ratio: 0.77) was observed between BRV and Cryptosporidium spp. infections, indicating complex ecological dynamics within the enteric microenvironment [7].

The age distribution of BRV infections is a critical epidemiological feature, with the highest prevalence consistently reported in calves between 0 and 14 days of age [7]. This age-specific susceptibility is attributable to the waning of maternally derived antibodies, the immaturity of the neonatal immune system, and the developmental regulation of glycan receptors in the neonatal gut that facilitate viral attachment and entry. The biological basis for this age restriction has been elucidated through structural studies demonstrating that the VP8* domain of certain bovine rotavirus strains, particularly those bearing the P[11] genotype, exhibits differential recognition of type I and type II precursor glycans that are developmentally regulated in the neonatal intestine [27]. This glycan specificity provides a molecular mechanism for the age-restricted tropism observed in neonatal calves and has implications for zoonotic transmission to human infants.

Regional Epidemiology in Asia

Asia represents a region of immense importance for understanding BRVA epidemiology, given the continent's large and diverse cattle populations, varied production systems, and the documented emergence of novel reassortant strains with zoonotic potential. In China, the world's largest cattle producer, BRVA prevalence is alarmingly high. A systematic review and meta-analysis encompassing 29 articles and data from 10,677 cattle estimated a pooled BRV prevalence of 46% (6,635/10,677), with significant regional variation [9]. The prevalence in Northeast China (40%) was significantly lower than in other regions, suggesting that climatic factors, management practices, or livestock density may influence transmission dynamics [9]. Importantly, this meta-analysis identified publication time, detection methods, age of cattle, and clinical symptoms as significant factors associated with prevalence estimates, highlighting the need for standardized diagnostic approaches in future surveillance efforts [9].

Among specific cattle populations in China, the prevalence of BRVA in diarrheic dairy calves is particularly striking. A study of 269 diarrheic samples from 23 farms across six provinces reported a 71% positivity rate, with G6P[1] identified as the predominant strain [3]. This finding is consistent with earlier reports from the same research group investigating BRVA in yaks on the Qinghai-Tibet Plateau, where 73.6% of 541 diarrheic samples from 69 farms across four provinces were BRVA-positive, with G6P[1] again predominating [1]. The yak study is particularly noteworthy because it represents the first comprehensive molecular characterization of BRVA in this iconic high-altitude species and revealed unique amino acid mutations in the VP7 and VP4 proteins that resulted in the clustering of these strains into an independent phylogenetic branch [1]. Furthermore, whole-genome analysis of a representative strain, QH-1, revealed a G6-P[1]-I2-R2-C2-M2-A3-N3-T6-E2-H3 genotype constellation, and phylogenetic analyses indicated that this strain was a reassortant of bovine, human, and ovine rotavirus origins, underscoring its public health significance [1]. The detection of G6 lineage VI strains in Chinese dairy calves that were closely related to yak strains suggests cross-species transmission between these bovine species and highlights the interconnectedness of BRVA epidemiology across different livestock populations [3].

In Japan, longitudinal surveillance of BRVA in dairy and beef calves from 2017 to 2020 revealed the circulation of multiple genotypes, including G6, G8, G10, P[1], P[5], and P[11], with G10P[11] being the most common combination (41.8%), followed by mixed infections with G6+G10P[5] (11.5%) [6]. This study, conducted on a vaccinated farm in Ibaraki Prefecture, demonstrated that despite improved hygiene protocols that reduced mortality and the detection of other viral pathogens, BRVA detection rates remained elevated in calves less than three weeks of age [6]. Phylogenetic analysis of these Japanese strains revealed clustering with bovine and other animal-derived RVA strains, suggesting the possibility of multiple reassortment events involving strains of bovine and other animal origins [6]. The persistence of BRVA circulation in vaccinated herds raises important questions about vaccine efficacy and the potential for immune escape by emerging variants. A separate Japanese study focusing on the development of genotype-specific anti-bovine rotavirus immunoglobulin Y (IgY) provided complementary epidemiological data, confirming the predominance of G6 and G10 genotypes in Japanese calves during the 2017–2020 period [2].

In Bangladesh, a comprehensive risk factor analysis conducted across three districts from January 2014 to October 2015 identified BRV in 23% of 200 diarrheic calves using rapid test strips, with subsequent confirmation by polyacrylamide gel electrophoresis [10]. Multivariable logistic regression analysis revealed that the odds of BRV infection were 3.8 times higher in Barisal district and 3.9 times higher in Madaripur district compared to Sirrajganj, indicating significant geographical heterogeneity in infection risk [10]. Age was a critical determinant, with calves aged ≤5 weeks having 3.1 times higher odds of infection compared to older calves [10]. Breed also influenced susceptibility, with crossbred calves (Holstein Friesian and Shahiwal) exhibiting 2.6 times higher odds of infection compared to indigenous breeds [10]. Genotyping of Bangladeshi strains revealed G6P[11] as the predominant genotype (94.4%), followed by G10P[11] (5.6%), with G6 strains showing 98.9–99.9% nucleotide identity to Indian strains, suggesting regional circulation of related lineages [10].

Regional Epidemiology in Europe

European BRVA epidemiology exhibits distinct patterns that reflect the continent's intensive cattle production systems, vaccination practices, and climatic conditions. In Spain, a comprehensive two-year study (2017–2018) of 237 diarrheic fecal specimens from calves younger than two months, originating from 193 dairy and beef farms across 29 provinces, revealed an individual prevalence of 57.8% for Cryptosporidium parvum, 50.6% for RVA, and 23.6% for BCoV, with 42.6% of samples harboring mixed infections [18]. Molecular characterization of 26 RVA-positive specimens identified G6, G10, G3, P[5], and P[11] genotypes, with G6P[5] and G6P[11] being the most prevalent combinations [18]. Notably, nucleotide sequence alignments of the VP7 gene revealed extensive genetic diversity, with up to 294 single nucleotide polymorphisms (SNPs) found in 869 base pairs of sequence at the G6 genotype (0.338 SNPs/nt), indicating a high mutation rate and ongoing viral evolution [18]. Phylogenetic analysis of G6 strains revealed four distinct lineages, with most Spanish strains clustering in lineage G6-IV, and the study highlighted discrepancies between circulating genotypes and those contained in commercial vaccines available in Spain [18].

In Ireland, a study conducted from 2006 to 2008 analyzed 272 stool samples from symptomatic calves and identified G6P[5] as the predominant genotype, accounting for 70% of samples (n=191), with G6P[11] and G10P[11] also detected [19]. Sequence analysis of the VP7 gene revealed that Irish G6 strains fell within Lineage IV, consistent with previous reports from Ireland [19]. The detection of unusual G and P combinations in this study raised concerns about the potential impact on rotavirus control programs, as the vaccines available at the time may not have offered complete protection against all circulating types [19].

Of particular significance in European BRVA epidemiology is the emergence of bovine-human reassortant strains with implications for human health. In the Czech Republic, surveillance of rotavirus strains from human patients with gastroenteritis during 2016–2019 unexpectedly revealed a high prevalence (9.3%) of G8P[8] strains [12]. Whole-genome analysis using next-generation sequencing demonstrated that these Czech G8 strains possessed a DS-1-like backbone, and phylogenetic analysis indicated that they had emerged following genetic reassortment between bovine and human rotaviruses [12]. This represents the first detection of bovine-human DS-1-like G8P[8] strains at a high rate in human patients in Central Europe, raising concerns about the establishment of this unusual genotype in the human population and highlighting the need for continuous rotavirus surveillance [12].

Regional Epidemiology in the Americas

The Americas present a diverse epidemiological landscape for BRVA, with studies from both North and South America contributing to our understanding of genotype distribution, transmission dynamics, and the impact of vaccination. In Brazil, a study conducted in southeastern and central-western regions from 2009 to 2010 examined 792 fecal samples from 65 dairy and beef herds and detected rotavirus in 5.05% of samples by polyacrylamide gel electrophoresis [24]. Molecular characterization revealed remarkable genotypic diversity, with G6P[11], G10P[11], G6P[5], G8P[5], G11P[11], and various mixed infections detected across different states [24]. The detection of G8 and G11 genotypes, which are less commonly reported in bovine populations, underscores the genetic plasticity of BRVA and the potential for novel genotype emergence through reassortment [24]. A subsequent study from the state of Goiás, Brazil, examining 331 samples from a dairy herd, reported a 9.9% rotavirus positivity rate and found that the majority of samples (51.6%) displayed multiple P genotypes, including typical human genotypes P[4] and P[6M], suggesting the occurrence of co-infections and genetic reassortment [30]. The detection of human genotypes in bovine samples provides compelling evidence for the zoonotic potential of rotaviruses and the bidirectional nature of interspecies transmission [30].

A particularly informative outbreak investigation in a beef cattle herd in Mato Grosso, central-western Brazil, documented an outbreak of neonatal diarrhea affecting 1,100 calves up to 30 days of age, with 80% morbidity and 12% mortality [34]. BRVA was identified in 53.3% (16/30) of diarrheic fecal samples, and genotyping revealed G6P[5] (n=6), G6P[11] (n=1), and G6P[X] (n=1) [34]. Immunohistochemical examination of necropsied calves confirmed BRVA antigen in intestinal tissues, and histopathological lesions included villus fusion and moderate multifocal lymphoplasmacytic enteritis [34]. This outbreak exemplifies the devastating impact of BRVA in unvaccinated or inadequately protected herds and highlights the importance of understanding the specific genotypes circulating in different production systems.

In Argentina, extensive surveillance conducted from 1997 to 2009 across the main livestock regions revealed that BRVA was detected in 30% (435/1462) of tested samples, corresponding to 49% (207/423) of studied outbreaks, with similar detection rates in beef (53%) and dairy herds (52%) [26]. A striking finding of this study was the different G/P-genotype distribution between exploitation types: G6(IV)P[5] was by far the most prevalent strain in beef herds (58%), whereas dairy herds exhibited a more even distribution of G6(III)P[11] (15%), G10P[11] (17%), G6(IV)P[5] (14%), and G6(IV)P[11] (6%) [26]. G8 strains were detected in two dairy farms in calves co-infected with G8+G6(III)P[11], and a high percentage of co-infections and co-circulation of different genotypes during the same outbreak were registered in both exploitation types (20% of outbreaks in beef herds and 23% in dairy herds), indicating a potential environment for reassortment [26]. Phylogenetic analyses of Argentinean strains demonstrated that G6(III), G10, P[5], and P[11] strains grouped together with human strains, highlighting their potential for zoonotic transmission [22]. Association between P[5] and G6(IV) was prevalent in beef herds, while P[11] was associated with G6(III) or G10 (lineages VI and V) in dairy herds, suggesting that host factors or management practices may influence genotype-specific transmission dynamics [22].

Regional Epidemiology in Africa and the Middle East

The African continent presents unique challenges for BRVA epidemiology, including limited surveillance infrastructure, diverse livestock production systems, and high rates of co-infection with other enteric pathogens. In Ethiopia, a preliminary cross-sectional study conducted from November 2018 to April 2019 in dairy farms of Addis Ababa examined 110 calves less than 30 days of age from 57 dairy herds and reported a BRV prevalence of only 3.64% (4/110) by sandwich ELISA [38]. This relatively low prevalence compared to other regions may reflect differences in diagnostic methods, sampling strategies, or true epidemiological differences, but the study was limited by its small sample size and cross-sectional design [38]. Notably, all rotavirus-positive calves were identified in small-scale dairy farms and in farms that reported mortality, suggesting that management factors may influence infection risk [38].

In Egypt, a comprehensive review of studies published over the last 30 years revealed rotavirus prevalence ranging from 15% to 100% in calves, with G6 as the predominant genotype, followed by G10 [29]. The review highlighted significant gaps in knowledge regarding molecular data of rotavirus infections in humans, animals, and environmental samples in Egypt, as well as the zoonotic potential of rotavirus disease [29]. The year-round occurrence of diarrhea with peaks during cold months suggests that environmental factors, including temperature and humidity, may influence viral transmission and persistence [29].

In Iran, a study of 581 stool specimens from diarrheic calves across 14 provinces detected RVA by RT-PCR in 16.2% (94/581) of samples, with no positive cases of rotavirus B or C detected [4]. Phylogenetic analysis of VP6 sequences revealed that all Iranian RVA strains belonged to genotype I2 and were classified into three different branches, with a specimen from Zanjan showing the highest divergence (maximum identity of 94%) and clustering with the Japanese strain R22 [4]. Importantly, human G and P genotypes were not found in the studied samples, suggesting that interspecies transmission from humans to cattle may be limited in this setting [4].

Zoonotic Implications and Inters

Genotypic Diversity and Evolution of Bovine Rotavirus A

Bovine rotavirus A (BRVA) represents a paradigmatic example of viral evolution driven by a segmented double-stranded RNA genome, host immune pressure, and ecological interfaces between livestock, wildlife, and human populations. The genotypic landscape of BRVA is characterized by a dynamic interplay between highly conserved viral machinery and hypervariable surface antigens, a duality that underpins both its persistence in bovine populations and its capacity for cross-species transmission. Understanding this diversity is not merely an academic exercise; it is fundamental to the design of effective vaccination strategies, the prediction of emerging zoonotic threats, and the implementation of surveillance programs that meet the standards set by the World Organisation for Animal Health (WOAH) and the Food and Agriculture Organization (FAO).

The Segmented Genome as an Engine of Diversity

The core of BRVA's evolutionary plasticity lies in its 11 double-stranded RNA gene segments, each encoding either a structural protein (VP1–VP4, VP6, VP7) or a non-structural protein (NSP1–NSP5/6). This segmented architecture allows for a unique mechanism of genetic exchange: reassortment. During co-infection of a single cell by two or more distinct rotavirus strains, progeny virions can package gene segments from different parental viruses, giving rise to novel genotype constellations. This process is not random; evidence from whole-genome analyses of both bovine and human strains reveals that certain gene segment combinations are selectively maintained, suggesting functional constraints that govern the "genetic backbone" of a strain [1, 21, 23].

The genotype constellation nomenclature, established by the Rotavirus Classification Working Group (RCWG), designates the genotype of each of the 11 segments in the order: Gx-P[x]-Ix-Rx-Cx-Mx-Ax-Nx-Tx-Ex-Hx. For bovine rotavirus A, a canonical "bovine-like" constellation has been repeatedly identified: G6/10-P[1/5/11]-I2-R2-C2-M2-A3/13-N2-T6/9-E2-H3 [1, 16, 20, 22]. This constellation is remarkably stable across geographically distant bovine populations, indicating a co-adapted gene complex that is optimally fit for the bovine enteric environment. However, within this backbone, significant variation occurs at the G (VP7) and P (VP4) loci, which encode the outer capsid proteins that are the primary targets of neutralizing antibodies.

Global Distribution and Shifting Paradigms of G and P Genotypes

For decades, the prevailing dogma held that bovine rotavirus A was predominantly associated with G6, G10, and G8 genotypes, combined with P[1], P[5], or P[11] types. Recent large-scale molecular epidemiological studies have confirmed this core but have dramatically expanded our understanding of its complexity.

G6 Genotype: A Master of Disguise G6 remains the most prevalent genotype worldwide, but its phylogenetic structure reveals a hidden diversity. Phylogenetic analyses of the VP7 gene have resolved G6 into multiple lineages (I through VI). Lineage IV appears to be the most globally distributed lineage, particularly in Europe and the Americas. For instance, G6 strains circulating in Spain between 2017 and 2018 predominantly clustered within lineage IV and exhibited an extraordinary degree of intra-lineage diversity, with up to 294 single nucleotide polymorphisms (SNPs) detected across an 869-base pair sequence, a SNP frequency of 0.338 per nucleotide [18]. This level of genetic drift within a single lineage suggests rapid evolution under neutralizing antibody pressure.

In China, a fascinating epidemiological shift has been documented. While early studies in dairy calves identified G6P[5] as the dominant combination [3], more recent surveillance from 2015 to 2018 across yak and dairy populations revealed the emergence of G6P[1] as the predominant genotype, with a distinct lineage assignment. Specifically, the G6 VP7 sequences from Chinese dairy calves clustered into lineage VI, which was previously undescribed in bovine populations and showed close genetic relatedness to strains circulating in yaks on the Qinghai-Tibet Plateau [1, 3]. This finding strongly suggests inter-species transmission between yak and cattle, facilitated by co-grazing practices. The G6P[1] strains from yaks also possessed unique amino acid substitutions in the VP7 and VP4 proteins that formed an independent phylogenetic clade, indicating adaptation to a novel host niche [1].

G10 Genotype: Emerging Dominance in Vaccinated Herds The G10 genotype, typically found in combination with P[11], has been reported with increasing frequency, particularly in Japan, Bangladesh, and parts of South America. In Japan, a longitudinal study from 2017–2020 on a vaccinated farm identified G10P[11] as the most common combination, accounting for 41.8% of the 122 positive samples analyzed [6]. This is of particular concern because the commercial vaccines used in that region contain G6 and G10, suggesting that the circulating G10 strain may have evolved antigenic differences from the vaccine strain. Indeed, phylogenetic analysis of these Japanese G10 strains showed clustering with other animal-derived rotaviruses, not with the vaccine strain, implying that vaccine-induced immunity may be selecting for antigenically divergent variants [6].

P[1], P[5], and P[11]: Differential Host Tropism and Geographic Partitioning The VP4 gene, encoding the spike protein responsible for initial attachment to host cells, shows distinct geographical and production-system associations. P[5] is strongly associated with G6 lineage IV strains and is predominant in beef herds in Argentina, where the G6(IV)P[5] combination was detected in 58% of outbreaks [26]. Conversely, P[11] is more frequently associated with G6 lineage III and G10 strains in dairy herds [22, 26]. This dichotomy suggests that VP4 tropism may influence transmission dynamics within different management systems, possibly due to differences in host density or age structure.

In Bangladesh, P[11] was found almost exclusively in combination with G6 (94.4% of typed strains), with the sequences showing >90% identity to each other, indicating a clonal expansion of a locally adapted lineage [10]. In contrast, in Iran, the VP6 gene, a group- and subgroup-specific antigen, was found to belong exclusively to genotype I2, but phylogenetic analyses of the I2 sequences revealed three distinct branches, with one Iranian strain clustering with the Japanese R22 strain, indicating long-distance genetic connectivity [4].

Mixed Infections: The Crucible of Evolution

The detection of mixed infections, where a single host is simultaneously infected by multiple rotavirus strains, is a critical indicator of reassortment potential. The frequency of mixed infections is alarmingly high in certain regions. In Brazil, a study from Goiás state reported that 51.6% of bovine rotavirus-positive samples exhibited multiple P genotypes, including mixtures of typical bovine P[1], P[5], and P[11] types, as well as unexpected human P[4] and P[6] genotypes [30]. This extraordinarily high frequency of mixed infections in a dairy herd provides a permissive environment for the generation of novel reassortants.

Similar patterns have been observed globally. In Argentina, 20–23% of rotavirus-positive outbreaks on beef and dairy farms showed co-circulation of multiple G and P genotypes [26]. In Japan, 11.5% of samples from a vaccinated farm contained mixed G6+G10P[5] infections [6]. The biological significance of these mixed infections extends beyond simple genotype mixing. Next-generation sequencing of mixed infections from sub-Saharan Africa revealed that a single bovine sample could harbor distinct genotypes for the same gene segment, with one segment (VP7) belonging to a G9 genotype of lineage VI that clustered with porcine reference strains, a clear indication of inter-species reassortment within the bovine host [25].

Zoonotic Spillover and the Bovine-Human Interface

The genotypic diversity of BRVA is not confined to bovines; it represents a reservoir for human rotavirus strains. Multiple lines of evidence demonstrate that bovine rotaviruses can cross the species barrier and cause disease in humans, either through direct zoonotic transmission or through the generation of human-bovine reassortants.

Direct Zoonotic Transmission: G6P[13] and G10P[13] Whole-genome characterization of human G6P[13] strains from Thailand revealed a genotype constellation (G6-P[13]-I2-R2-C2-M2-A3-N2-T6-E2-H3) that is virtually indistinguishable from the classic bovine backbone [23]. Phylogenetic analysis placed the VP7 gene of these human strains within G6 lineage-5, alongside bovine strains, clearly separate from other G6P[13] strains in lineages 2 and 6. This indicates multiple independent bovine-to-human transmission events [23]. Similarly, a G10P[13] strain from a diarrheic child in Thailand had all 11 genes of artiodactyl (likely bovine) origin, confirming direct zoonotic acquisition [16].

Bovine-Human Reassortants: The DS-1-Like G8P[8] Emergence Perhaps the most striking example of bovine rotavirus genes entering the human population is the emergence of DS-1-like G8P[8] strains. These strains, which possess a human Wa-like P[8] genotype on a DS-1-like backbone (I2-R2-C2-M2-A2-N2-T2-E2-H2), have been detected at high frequencies in Thailand, Vietnam, the Czech Republic, and Ghana [12, 21, 28]. Phylogenetic dissection of the 2013–2014 Thai G8P[8] strains revealed that six of the 11 gene segments (VP7, VP6, VP1, NSP2, and others) originated from bovine or bovine-like viruses, while the remaining segments were derived from human DS-1-like strains [21]. These bovine-human reassortants have now spread across Asia and into Europe, with Czech strains from 2016–2019 showing 99% nucleotide identity to Vietnamese strains from 2014–2015, suggesting a rapid international dissemination event [12].

The 116E and RotaTeq Paradigm: Bovine Backbones in Human Vaccines The utility of the bovine rotavirus genetic backbone is dramatically illustrated by two globally important vaccines. The RotaTeq vaccine (Merck) is a pentavalent human-bovine reassortant vaccine based on the bovine G6P[5] WC3 strain, into which human VP7 genes (G1–G4) and VP4 (P[8]) have been inserted [14]. The 116E vaccine (Rotavac, Bharat Biotech) is a natural human-bovine reassortant (G9P[11]) isolated from an asymptomatic Indian neonate, which possesses a bovine P[11] VP4 and a human G9 VP7 on a bovine backbone [36]. The success of these vaccines underscores the robustness and safety of the bovine genetic backbone for human immunization. However, it also highlights the potential for vaccine-derived reassortants to circulate. The WC3 P[5] VP8* domain has been shown to recognize both α2,6-linked sialic acid and αGal histo-blood group antigens (HBGAs), but neither ligand is expressed on human intestinal epithelial cells, explaining the lack of natural human infection by P[5] strains [14].

Evolutionary Drivers: Vaccination, Host Adaptation, and Ecological Niches

The selective pressures driving BRVA evolution are multifaceted. Vaccination exerts a powerful selective force. Studies from Brazil and Japan have documented the emergence of rotavirus strains during diarrhea outbreaks in herds vaccinated with G6P[1] and G10P[11] genotypes, where the outbreak strain was a heterotypic G6P[5] [20]. This phenomenon, termed "vaccine escape" or "strain replacement", suggests that current vaccines may not provide complete homotypic protection against all circulating G6 lineages.

Host adaptation also plays a critical role. The G6P[1] strains isolated from yaks on the Qinghai-Tibet Plateau showed unique amino acid substitutions in VP7 and VP4 that were not present in bovine strains from lower altitudes, suggesting high-altitude adaptation [1]. Furthermore, the VP8* domain of bovine rotaviruses exhibits differential glycan binding. The G10P[11] strains, which are particularly associated with neonatal diarrhea, possess a VP8* that recognizes type I and type II precursor glycans. These glycans are developmentally regulated in the neonate gut and are abundant in bovine and human milk, providing a molecular basis for the age-restricted tropism of these strains [27].

Quantitative Genetic Diversity: A Measure of Evolutionary Rate

The nucleotide diversity within BRVA populations is staggering. The Spanish study by Benito et al. (2020) calculated SNP frequencies of 0.338 per nucleotide for the G6 VP7 gene, meaning that for every three nucleotides, one is variable [18]. This is comparable to the genetic diversity observed in human influenza A virus hemagglutinin. The high error rate of the RNA-dependent RNA polymerase, compounded by the frequent occurrence of recombination-like events (reassortment), allows BRVA to rapidly explore sequence space. The presence of multiple lineages within a single genotype (e.g., G6 lineages III, IV, V, and VI) indicates that multiple evolutionary lineages are circulating simultaneously, often in the same geographical region and even on the same farm [22, 26]. This co-circulation provides the raw material for future reassortment events.

The Role of Non-Structural Genes in Genotypic Diversity

While much attention focuses on VP7 and VP4, the non-structural protein-encoding genes (NSP1–NSP5) also contribute significantly to the diverse genotype constellations observed. The NSP1 gene, in particular, shows marked variation. Bovine rotaviruses typically possess an A3 or A13 genotype for NSP1, but reassortment events can introduce human A1 or porcine A8 genotypes [1, 21]. The NSP4 gene, encoding an enterotoxin that can induce diarrhea independent of viral replication, is almost exclusively genotype E2 in bovine strains, but human-bovine reassortants may acquire E1 [23]. The NSP2 and NSP5 genes, involved in viroplasm formation and genome replication, exhibit a strong phylogenetic signal linking bovine strains to other artiodactyls, with the T6 (NSP3) and H3 (NSP5) genotypes being hallmark features of the bovine backbone [16, 20].

Diagnostic Methods for Bovine Rotavirus A

The accurate and timely diagnosis of Bovine Rotavirus A (BRVA) infection is paramount for implementing effective control strategies, understanding epidemiological dynamics, and mitigating the substantial economic losses incurred by the global cattle industry. The diagnostic landscape for BRVA has evolved considerably, transitioning from classical virological and electrophoretic techniques to highly sensitive molecular assays and, more recently, to innovative biosensor platforms. The choice of diagnostic method is dictated by the specific objective, whether for rapid on-farm clinical decision-making, large-scale epidemiological surveillance, molecular characterization for vaccine strain selection, or research into viral pathogenesis. This section provides an exhaustive analysis of the diagnostic armamentarium available for BRVA, critically evaluating each method’s principles, performance characteristics, applications, and limitations within the context of contemporary veterinary virology.

Classical and Conventional Diagnostic Approaches

Historically, the diagnosis of BRVA relied on methods that detect the virus, its antigens, or its nucleic acid through relatively low-tech but informative means. These techniques remain valuable, particularly in resource-limited settings or when a broad, non-specific screening tool is required.

Polyacrylamide Gel Electrophoresis (PAGE) and Silver Staining: The rotavirus genome consists of 11 segments of double-stranded RNA (dsRNA), which exhibit a characteristic electrophoretic migration pattern when subjected to PAGE. This technique, coupled with silver staining, allows for the visualization of the viral genome directly from fecal samples. The distinct electropherotype, the specific migration pattern of the 11 segments, serves as a powerful diagnostic and epidemiological tool. PAGE can differentiate group A rotaviruses from other rotavirus groups (B and C) based on the distinct migration patterns of their genomic segments, particularly the VP6 gene segment [4, 34]. For instance, Nazaktabar and Madadgar utilized PAGE to confirm BRVA positivity in 22.16% of diarrheic calf samples in Iran, while simultaneously ruling out the presence of bovine rotavirus B and C in the same population [4]. Similarly, Rondelli et al. employed silver-stained PAGE (ss-PAGE) to identify BRVA in 53.3% of samples from a severe diarrhea outbreak in Brazilian beef calves [34]. The method’s primary advantage is its ability to detect mixed infections, as the presence of more than 11 bands in the electropherotype is a clear indicator of co-infection with multiple rotavirus strains [25]. However, PAGE is labor-intensive, requires a relatively high viral load, is not quantitative, and demands considerable technical expertise for interpretation, which limits its use in high-throughput diagnostic laboratories.

Electron Microscopy (EM) and Immune Electron Microscopy (IEM): Direct visualization of rotavirus particles using negative-stain electron microscopy was a cornerstone of early rotavirus diagnosis. The characteristic wheel-like morphology (from which the name ‘rotavirus’ is derived) allows for unambiguous identification. Immune electron microscopy (IEM), which involves incubating the sample with specific antiserum to aggregate viral particles, enhances sensitivity and provides serological specificity. While EM and IEM were instrumental in the initial discovery and classification of rotaviruses, they are now rarely used for routine diagnosis due to the high cost of equipment, the need for highly trained personnel, and the superior sensitivity and throughput of molecular methods. Nevertheless, IEM was crucial in the first detection of bovine group B rotavirus (the Nemuro strain) in Japan, confirming the viral etiology of an epizootic diarrhea outbreak in adult cows [43].

Rapid Immunochromatographic Assays (Lateral Flow Tests): For on-farm or field-based diagnosis, rapid immunochromatographic (IC) tests offer the significant advantage of speed and simplicity, providing results within 15–30 minutes without the need for specialized laboratory equipment. These tests typically detect the VP6 antigen, a highly conserved group-specific protein. A comprehensive evaluation by Klein et al. compared a commercial rapid IC test for BRVA against a reverse transcriptase polymerase chain reaction (RT-PCR) gold standard. The study found the rapid test to have high specificity (95.3%) but only moderate sensitivity (71.9%) [41]. This indicates that while a positive result is highly reliable, a negative result does not rule out infection, particularly in samples with low viral loads. The moderate sensitivity is a critical limitation, as false negatives can lead to a failure to implement timely biosecurity measures. Despite this, IC tests remain widely used for their practicality, and their performance can be context-dependent, influenced by factors such as the stage of disease and sample quality. Uddin et al. successfully used a rapid test-strip (BIO K 152) as a primary screening tool for BRVA in Bangladesh, followed by confirmatory PAGE and RT-PCR [10].

Immunohistochemistry (IHC): For post-mortem diagnosis and pathogenesis studies, immunohistochemistry is an invaluable technique. It allows for the direct visualization of viral antigen within formalin-fixed, paraffin-embedded tissue sections, providing spatial and cellular resolution of infection. Singh et al. employed IHC to detect BRVA antigen in the intestinal tissues of naturally infected calves, demonstrating its presence within the lining epithelium of villi, Peyer’s patches in the ileum, and in lymphocytes and macrophages of the mesenteric lymph nodes [32]. This technique confirmed the viral etiology of enteric lesions, such as villus shortening and fusion, and provided insights into viral dissemination beyond the intestinal epithelium. IHC is highly specific but is relatively insensitive compared to molecular methods, requires specialized antibodies, and is too labor-intensive and time-consuming for routine diagnostic use. It remains a gold standard for confirming the role of BRVA in disease pathogenesis in research and diagnostic pathology.

Molecular Diagnostic Methods: The Gold Standard

The advent of molecular biology has revolutionized BRVA diagnostics, offering unparalleled sensitivity, specificity, and the capacity for genotyping. These methods have become the gold standard for both clinical diagnosis and epidemiological surveillance.

Reverse Transcription Polymerase Chain Reaction (RT-PCR) and its Variants: RT-PCR is the most widely used molecular method for BRVA detection. It involves the reverse transcription of viral dsRNA into complementary DNA (cDNA), followed by PCR amplification of a specific gene target. The VP6 gene is the most common target for group A detection due to its high conservation across all RVA strains [4, 13, 42]. Numerous studies have demonstrated the superior sensitivity of RT-PCR over traditional methods. For instance, Yan et al. detected BRVA in 73.6% of yak diarrheic samples using RT-PCR [1], while Liu et al. reported a 71% positivity rate in Chinese dairy calves [3]. These detection rates are substantially higher than those typically reported with PAGE or antigen ELISA, underscoring the enhanced sensitivity of nucleic acid amplification.

Conventional RT-PCR is a qualitative endpoint assay. Its primary power lies in its ability to generate amplicons for subsequent sequencing and genotyping. Semi-nested and multiplex RT-PCR are critical advancements for genotyping. Semi-nested RT-PCR uses a second round of amplification with internal primers to increase sensitivity and specificity for typing the outer capsid genes, VP7 (G genotype) and VP4 (P genotype). This approach is the cornerstone of molecular epidemiological studies. For example, Hasan et al. used semi-nested multiplex RT-PCR to characterize the G and P genotypes of 122 BRVA-positive samples from a vaccinated bovine farm in Japan, identifying G6, G8, G10, P[1], P[5], and P[11] genotypes [6]. Similarly, Benito et al. used RT-PCR and sequencing to determine the G and P genotypes of BRVA strains in Spain, revealing the predominance of G6P[5] and G6P[11] and a high frequency of single nucleotide polymorphisms (SNPs) [18]. This genotyping capability is essential for monitoring circulating strains, detecting emerging genotypes, and assessing vaccine efficacy, as mismatches between vaccine and field strains can lead to vaccination failures [15, 20].

Real-Time or Quantitative RT-PCR (RT-qPCR): RT-qPCR offers the advantage of quantification, allowing for the determination of viral load in a sample. This is achieved by measuring the fluorescence emitted during amplification, which is proportional to the amount of PCR product. RT-qPCR is more sensitive than conventional RT-PCR and eliminates the need for post-amplification gel electrophoresis, reducing turnaround time and contamination risk. Benito et al. employed RT-qPCR for the initial screening of BRVA in Spanish calves, achieving a detection rate of 50.6% [18]. The quantitative nature of this assay is valuable for research applications, such as correlating viral load with disease severity or evaluating the efficacy of antiviral treatments. However, the higher cost of equipment and reagents can be a barrier to widespread adoption in some diagnostic settings.

Reverse Transcription Loop-Mediated Isothermal Amplification (RT-LAMP): As a field-deployable alternative to PCR, RT-LAMP is an isothermal nucleic acid amplification technique that amplifies DNA with high specificity, efficiency, and rapidity under a constant temperature (typically 60-65°C). A landmark study by Xie et al. developed an RT-LAMP assay targeting the VP6 gene of BRVA. The assay could be completed in 60 minutes in a simple water bath, and the results could be visualized directly by eye or under UV light. The analytical sensitivity was remarkable, detecting as few as 3.32 copies of the target gene, which was comparable to or better than RT-qPCR. The assay showed no cross-reactivity with other common bovine pathogens [42]. This makes RT-LAMP an exceptionally promising tool for point-of-care diagnostics in well-equipped laboratories or even in field settings, as it requires minimal instrumentation. Its high sensitivity and specificity, combined with its simplicity and speed, position it as a powerful diagnostic for rapid outbreak response.

Gold Nanoparticle-Assisted PCR (nanoPCR): A recent innovation to further enhance PCR sensitivity involves the use of gold nanoparticles (GNPs). Wang et al. developed a dual-priming oligonucleotide (DPO) system combined with GNPs (DPO-nanoPCR) for the simultaneous detection of BRV, bovine parvovirus (BPV), and bovine viral diarrhea virus (BVDV). The DPO primers provide high specificity by minimizing non-specific priming, while the GNPs improve amplification efficiency, likely through enhanced heat transfer. The DPO-nanoPCR assay demonstrated a 100-fold increase in sensitivity compared to conventional PCR, with detection limits as low as 9.40 × 10² copies/μL for the BRV VP6 gene. Furthermore, the assay tolerated a wide range of annealing temperatures (41–65°C), simplifying optimization [13]. This multiplex capability is particularly valuable for diagnosing mixed infections, which are common in neonatal calf diarrhea [7, 39, 40]. The DPO-nanoPCR represents a significant technological advance, offering a powerful, simple, and highly sensitive tool for the differential diagnosis of enteric pathogens.

Serological and Immunological Assays

Serological methods detect host antibodies against BRVA, providing evidence of past infection or vaccination. While not useful for diagnosing acute disease, they are essential for seroprevalence studies and vaccine response monitoring.

Enzyme-Linked Immunosorbent Assay (ELISA): ELISA is a versatile platform used for both antigen detection (directly in feces) and antibody detection (in serum or milk). Antigen-capture ELISA is a common alternative to RT-PCR for clinical diagnosis, offering good sensitivity and high throughput. Debelo et al. used a commercial sandwich ELISA to screen for BRVA in diarrheic calves in Ethiopia, reporting a prevalence of 3.64% [38]. While less sensitive than RT-PCR, ELISA is more practical for large-scale screening in laboratories with standard equipment.

Indirect ELISA for Antibody Detection: For serological surveys, an indirect ELISA is the method of choice. A recent study by Niu et al. developed a highly specific and sensitive indirect ELISA using a recombinant VP6 protein produced in a eukaryotic expression system. The assay was optimized with a cut-off OD450 value of 0.357, showed excellent reproducibility (coefficient of variation <10%), and could detect serum antibodies at a dilution of up to 1:2¹⁷ [5]. This assay provides a robust tool for large-scale epidemiological investigations to determine the seroprevalence of BRVA in cattle populations, which is critical for understanding the force of infection and evaluating vaccination programs.

Immunoglobulin Yolk (IgY) Technology: A novel immunological approach involves the production of specific antibodies in chicken egg yolks (IgY). Odagiri et al. developed genotype-specific anti-BRVA IgYs by immunizing hens with G6P[5] and G10P[11] strains. These IgYs demonstrated strong cross-reactivity and neutralizing activity against BRVA strains sharing the same G and/or P genotypes [2]. While primarily a therapeutic or prophylactic tool (passive immunization), the development of such IgYs also provides a source of highly specific reagents for diagnostic assays, such as in antigen-capture ELISAs or IHC.

Advanced and Emerging Diagnostic Technologies

The frontier of BRVA diagnostics is being shaped by biosensor technology and high-throughput sequencing, offering unprecedented sensitivity and the ability to characterize the entire viral genome.

Affinity Peptide-Based Electrochemical Biosensors: A revolutionary approach to rapid, ultra-sensitive detection is the use of electrochemical biosensors. Cho et al. developed a biosensor by immobilizing a BRVA-specific affinity peptide, identified via phage display, onto a gold electrode. Binding of the virus to the peptide was detected using square wave voltammetry, a highly sensitive electrochemical technique. This system achieved a remarkable limit of detection (LOD) of 5 copies/mL and a limit of quantification (LOQ) of 2.14 × 10² copies/mL [11]. This sensitivity far exceeds that of conventional RT-PCR and approaches single-virus detection. Such biosensors hold immense promise for developing point-of-care devices that are rapid, portable, and require minimal sample preparation, potentially enabling real-time monitoring of BRVA in livestock operations.

Next-Generation Sequencing (NGS) and Whole-Genome Analysis: NGS technologies, such as those provided by Illumina and Ion Torrent platforms, have transformed our understanding of rotavirus evolution and diversity. NGS allows for the complete genome sequencing of BRVA strains directly from clinical samples, even in cases of mixed infections. This capability is critical for identifying reassortment events, tracking zoonotic transmission, and understanding the molecular basis of host range and virulence. For example, Nyaga et al. used NGS to characterize mixed rotavirus infections in bovine, porcine, and human samples from sub-Saharan Africa, revealing complex evolutionary histories involving interspecies transmission [25]. Similarly, the characterization of novel bovine-human reassortant strains, such as the G8P[8] DS-1-like strains in the Czech Republic and Thailand, has been entirely dependent on whole-genome sequencing to elucidate their unique genotype constellations and origins [12, 21]. NGS is not yet a routine diagnostic tool due to its cost and bioinformatics requirements, but it is indispensable for advanced molecular epidemiology and public health surveillance.

Metagenomic and Microbiome Analysis: Beyond detecting the virus itself, advanced sequencing techniques are being used to study the impact of BRVA infection on the gut microbiome. Kim et al. and Murtaza et al. used 16S rRNA gene amplicon sequencing to characterize the fecal microbiota of rotavirus-infected calves. These studies revealed that BRVA infection induces significant dysbiosis, characterized by a decrease in microbial diversity and an enrichment of potentially pathogenic bacteria like Enterococcus, Streptococcus, and Escherichia-Shigella, alongside a depletion of short-chain fatty acid-producing bacteria [8, 35]. While not a direct diagnostic for BRVA, this metataxonomic approach provides a holistic view of the disease state and can identify microbial biomarkers associated with infection and recovery, offering new

Genomic Reassortment and Zoonotic Potential

The segmented nature of the rotavirus A (RVA) genome, comprising 11 discrete double-stranded RNA segments, is the fundamental engine driving its remarkable genetic plasticity. For Bovine Rotavirus A (BRVA), this genomic architecture facilitates a sophisticated evolutionary strategy, reassortment, whereby co-infection of a single host cell with two or distinct RVA strains can yield progeny viruses with novel combinations of gene segments. This process is not merely a laboratory curiosity; it is a potent, field-proven mechanism for generating genetic diversity, enabling cross-species transmission, and creating viruses with altered host range, virulence, and antigenic profiles. The zoonotic potential of BRVA, therefore, is inextricably linked to its capacity for genomic reassortment, particularly with human RVA strains, and represents a significant, ongoing threat to public health that demands continuous genomic surveillance at the human-animal interface.

The primary biological prerequisite for reassortment is the occurrence of mixed infections. Epidemiological data from across the globe indicate that co-infections with multiple BRVA genotypes are not rare events but rather a common feature of the bovine enteric landscape. A comprehensive study of Argentinean cattle from 2004 to 2010 documented a high percentage of co-infections and co-circulation of distinct genotypes during the same outbreak, affecting 20% of beef and 23% of dairy herds [26]. This simultaneous presence creates a "mixing vessel" environment within the calf gut, allowing for the shuffling of gene segments between co-circulating strains. The situation is further complicated by the frequent detection of mixed P-type genotypes. Research in Brazil identified a surprisingly high frequency of multiple P genotypes within single bovine samples, including the common bovine P[5] and P[11] alongside the atypical presence of human-like P[4] and P[6] genotypes, providing direct molecular evidence of extensive genetic reassortment [30]. The bovine host, particularly the neonatal calf with its naïve immune system and high susceptibility to infection, thus functions as a critical ecological nexus where bovine, human, and potentially other animal RVA strains can converge and reassort.

The evidence for reassortment extends beyond observational epidemiology to the direct genomic characterization of field strains. The whole-genome sequencing of BRVA strains has repeatedly revealed chimeric constellations of genes with origins in different host species. The isolation of the G6P[1] strain QH-1 from yaks in China is a paradigmatic example. This strain was identified as a multi-species reassortant, with its genetic backbone comprising segments closely related to those from bovine, human, and ovine RVA, a finding that underscores the complex interspecies dynamics at play in livestock populations and their clear public health significance [1]. Similarly, in Spain, the detection of G3 genotypes alongside the more common G6 and G10 in diarrheic calves suggests ongoing genetic flux and potential incursions from other host reservoirs [18]. These findings demonstrate that the bovine RVA gene pool is not isolated but is continually being augmented and reshaped through reassortment with RVA strains from other mammalian species.

The most direct and alarming consequence of BRVA reassortment is the generation of novel viruses capable of infecting and causing disease in humans. A constellation of studies has documented the emergence of human RVA strains bearing a "bovine-like" genetic backbone, which are clear product of zoonotic reassortment events. A striking example is the emergence and rapid spread of DS-1-like G8P[8] rotaviruses. These strains, first detected in Southeast Asia and subsequently in Europe, possess a unique genotype constellation (G8-P[8]-I2-R2-C2-M2-A2-N2-T2-E2-H2) that is a mosaic of human and bovine gene segments. Detailed full-genome analysis of Thai strains revealed that their VP7 (G8) genes were of bovine origin, while their VP4 (P[8]) genes were derived from human strains, the result of a complex series of reassortment events between co-circulating human DS-1-like strains and bovine RVA [21]. The detection of these same DS-1-like G8P[8] strains at a high rate in human patients in the Czech Republic confirmed that this reassortment event was not a geographically isolated phenomenon but a transcontinental public health event [12]. These strains represent a successful and expanding lineage of bovine-human reassortants capable of sustained human-to-human transmission.

Beyond the G8P[8] lineage, multiple other "spillover" events have been documented, further illustrating the breadth of BRVA's zoonotic potential. Whole-genome characterization of a human G10P[13] strain from a child with severe diarrhea in Thailand revealed a genotype constellation (G10-P[13]-I2-R2-C2-M2-A3-N2-T6-E2-H3) that is almost entirely of artiodactyl (likely bovine) origin, providing strong evidence for direct zoonotic transmission of a bovine RVA strain with minimal reassortment [16]. Similarly, a human G6P[13] strain from the same region was found to possess a bovine genetic backbone (G6-P[13]-I2-R2-C2-M2-A3-N2-T6-E2-H3), with only two gene segments (VP1 and NSP2) being of human origin, indicating that this strain arose from an interspecies transmission event followed by a limited reassortment with a human strain [23]. Even more complex are strains like the human G3P[9] isolate from South Korea, which was identified as a feline-bovine reassortant, with its VP1, VP2, VP3, VP6, and NSP2 genes being related to bovine RVA strains, while others were of feline origin [31]. These cases collectively demonstrate that bovine RVA genes are a recurring and significant component in the emergence of novel human pathogens, facilitated by both direct transmission and stepwise reassortment.

The molecular determinants that govern the host range and zoonotic potential of BRVA are increasingly understood at a structural level, particularly in relation to the VP8* domain of the VP4 spike protein. The VP8* domain is responsible for the initial attachment of the virus to host cell glycans, a critical step for infection. The bovine G6P[5] WC3 strain, used as the backbone for the RotaTeq vaccine, has been shown to recognize both α2,6-linked sialic acid and the αGal histo-blood group antigen (HBGA) [14]. Critically, neither of these ligands is expressed on human small intestinal epithelial cells, explaining the natural host restriction of P[5]-bearing bovine strains. However, the fact that the P[5]-bearing vaccine strains can still infect human intestinal cells suggests the use of alternative, non-glycan receptors, highlighting the potential for host range expansion through VP4 mutations [14]. In contrast, the neonate-specific G10P[11] bovine-human reassortant strains have evolved a distinct glycan-binding specificity. X-ray crystallography of the VP8* domain from a G10P[11] strain revealed a unique binding site that recognizes precursor glycans (type I and type II), which are developmentally regulated in the neonatal gut and abundant in milk, providing a molecular basis for their age-restricted tropism and ability to infect human neonates [27]. This detailed structural understanding underscores that host range is a finely tuned molecular trait, and that even minor sequence alterations in the VP8* domain can dramatically shift glycan specificity, potentially enabling a bovine-adapted strain to overcome the human host's glycan barrier.

The public health implications of BRVA genomic reassortment are profound and are recognized by global health authorities. Data from the World Health Organization (WHO) and the Food and Agriculture Organization (FAO) consistently highlight that emerging zoonotic diseases, many of which are RNA viruses, pose a constant threat to global health security. The capacity of BRVA to generate novel reassortant strains that can infect humans, as documented in Asia, Europe, and Africa, directly challenges the long-term efficacy of current rotavirus vaccines. The live, attenuated rotavirus vaccines in widespread use, such as Rotarix and RotaTeq, are designed to protect against the most common human G and P types. The emergence and global spread of bovine-human reassortant strains like G8P[8], which possess a bovine-derived VP7 gene, could potentially escape vaccine-induced immunity, as the G8 genotype is not included in the most widely used vaccines. This is not a theoretical concern; post-vaccination surveillance in countries like Ghana has already identified novel G8P[6] human-bovine reassortant strains, underscoring the dynamic co-evolution of vaccine pressure and reassortment-driven viral diversity [28]. The sustained efficacy of the human-bovine reassortant vaccine (116E, Rotavac) in Indian infants, while demonstrating a successful example of using a natural reassortant, also highlights the complex interplay between vaccine-induced immunity and the circulating, evolving virus population [36, 37].

In conclusion, BRVA is not a static veterinary pathogen. Its segmented genome makes it a master of genetic exchange, and the bovine enteric ecosystem serves as a powerful crucible for generating novel reassortant viruses. The documented emergence of multiple, genetically distinct bovine-human reassortant strains in human populations proves that BRVA possesses a tangible and significant zoonotic potential. This potential is driven by the high frequency of mixed infections in cattle, the ability of bovine RVA genes to mix with human RVA genes, and the fine-tuned molecular mechanisms of host cell attachment that can be overcome through reassortment. Consequently, the control of BRVA cannot be viewed solely as an animal health issue. It is an integral component of One Health surveillance. The continuous, coordinated genomic monitoring of RVA strains in both cattle and human populations, particularly in regions with high livestock density and close human-animal contact, is not optional but a critical imperative for anticipating, detecting, and responding to the emergence of the next pandemic-capable rotavirus strain.

Immunoprophylaxis Strategies for Bovine Rotavirus A

The implementation of effective immunoprophylaxis against Bovine Rotavirus A (BRVA) represents a cornerstone of neonatal calf health management worldwide, given the virus's ubiquitous nature, high morbidity rates, and profound economic impact on both dairy and beef production systems. The World Organisation for Animal Health (WOAH) recognizes rotaviral diarrhea as a disease of significant economic consequence, necessitating rigorous control measures. The strategies for immunoprophylaxis are broadly categorized into active immunization of the dam to enhance passive transfer of immunity via colostrum, direct vaccination of the neonate, and the application of heterologous passive immunotherapeutics such as egg-derived immunoglobulin Y (IgY). The development and refinement of these strategies are inextricably linked to the profound genetic and antigenic diversity of circulating BRVA strains, a dynamic landscape defined by the continuous emergence of novel G and P genotype combinations and interspecies reassortment events [1, 3, 6, 18, 22].

Active Immunization: Vaccination of the Dam and the Neonate

The most widely deployed immunoprophylactic approach involves the vaccination of pregnant dams to elevate the titer of rotavirus-specific immunoglobulin G (IgG) in the colostrum. This strategy leverages the natural passive transfer of immunity, wherein neonatal calves acquire critical protection through the ingestion of antibody-rich colostrum within the first critical hours of life. Commercial vaccines, often containing inactivated or modified-live virus strains representing common genotypes such as G6P[1] and G10P[11], are administered to cows during the dry period to boost humoral immunity [15, 20]. The efficacy of this approach, however, is frequently compromised by a critical immunological mismatch: the genotype composition of the vaccine may not align with the genotypes circulating in the field. A longitudinal study comparing vaccinated and unvaccinated dairy herds demonstrated that the vaccine used contained G6P[1] and G10P[11], yet the predominant strain infecting calves in the vaccinated herd was G6P[11], while the unvaccinated herd harbored G6P[5] [15]. This disparity strongly suggests that vaccination-induced immunity, while providing some level of cross-protection, may be insufficient against heterotypic strains, leading to breakthrough infections and clinical disease.

This problem of genotype mismatch is a recurring theme in BRVA epidemiology. Investigations in Spain revealed that the circulating genotypes, predominantly G6P[5] and G6P[11], were not represented in the commercial vaccines available at the time, raising concerns about the practical efficacy of blanket vaccination programs [18]. Similarly, a large-scale outbreak in a vaccinated Brazilian beef herd, characterized by 80% morbidity and 12% mortality in calves, was attributed to a wild-type G6P[5] strain [20]. The authors emphasized that the constellation of the outbreak strain, G6(IV)-P5-I2c-R2-C2-M2-A3-N2-T6-E2e-H3a, underscored the critical importance of homotypic immunity, particularly against the P[5] genotype, for effective protection [20]. These findings are not isolated; surveillance across Japan, China, and Argentina consistently shows that while G6 and G10 genotypes dominate, the specific P genotype combinations (P[1], P[5], P[11]) and the lineages within them vary significantly, often diverging from vaccine strains [2, 6, 22, 26]. For instance, Argentinean bovine RVA strains from both beef and dairy herds were phylogenetically distinct from the lineage containing vaccine strains, particularly for the G6 genotype, further highlighting the risk of diminished vaccine-driven protection in the face of evolving field viruses [22].

Direct neonatal vaccination is a less common strategy but has been explored using modified-live virus approaches to induce active immunity in the calf prior to the waning of maternal antibodies. A notable development in this arena is the construction of reassortant vaccines based on the Jennerian approach, where the VP7 gene of a bovine rotavirus (encoding a G6 specificity) is placed onto the backbone of an attenuated ovine rotavirus strain (LLR-85). This bivalent vaccine candidate, combining the reassortant R191 (G6) with the parental LLR-85 (G10), was shown to be immunogenic in colostrum-deprived calves, inducing significant serum IgG and IgA responses with minimal viral shedding [45]. This strategy aims to provide broader coverage against the two most common bovine G genotypes. While promising, the widespread adoption of neonatal vaccination faces logistical hurdles, including the need for multiple doses, cost-effectiveness, and the challenge of overcoming maternal antibody interference in field settings.

Passive Immunization: Colostrum and Egg-Derived Antibodies

Beyond vaccinating the dam, alternative passive immunization strategies have been developed to provide immediate, pathogen-specific protection to neonates. Hyperimmune bovine colostrum (HBC) represents one such approach. While HBC is often produced by immunizing cows with human rotavirus strains for use in human infants, recent research has demonstrated that a more conservative approach, immunizing pregnant cows with the conventional bovine rotavirus vaccine, is sufficient to enhance the anti-rotavirus activity of colostrum, making it a viable functional food for calves [44]. This method circumvents the regulatory and safety concerns associated with using human pathogens for bovine immunization.

A parallel and increasingly attractive strategy involves the production of anti-rotavirus immunoglobulin Y (IgY) from the eggs of immunized hens. An elegant study conducted in Japan developed genotype-specific IgYs by immunizing hens with two prevalent bovine RVA strains, G6P[5] and G10P[11], selected based on a comprehensive epidemiological survey from 2017-2020 [2]. The resulting IgYs demonstrated remarkably strong cross-reactivity in neutralization assays against bovine RVAs sharing the same G and/or P genotypes [2]. This critical finding provides proof-of-concept for a passive immunization tool that could be tailored to the regional molecular epidemiology of BRVA. The oral administration of such IgY cocktails to newborn calves offers a non-invasive, scalable, and highly specific method to provide immediate protection during the vulnerable neonatal period, bypassing the limitations of maternal vaccination when colostrum quality or quantity is suboptimal.

Novel and Adjunctive Approaches: Probiotics and Biosensor Detection

The understanding that BRVA infection induces profound gut dysbiosis, characterized by a decrease in beneficial short-chain fatty acid-producing bacteria like Faecalibacterium and Ruminococcus, and an increase in pathogenic taxa such as Escherichia-Shigella [8], has opened the door for adjunctive prophylactic strategies. Probiotic administration is emerging as a promising tool to support immunoprophylaxis by mitigating rotavirus-induced dysbiosis. A study employing 16S metagenomic analysis demonstrated that treatment of rotavirus-infected Sahiwal calves with Limosilactobacillus fermentum significantly ameliorated the dysbiosis, restoring the abundance of Firmicutes and reducing Proteobacteria, thereby bringing the microbial community structure closer to that of healthy controls [35]. This suggests that probiotics could be integrated into immunoprophylaxis protocols to bolster gut health and resilience, potentially enhancing the efficacy of active or passive immunization programs.

Finally, the effectiveness of any immunoprophylaxis strategy is contingent upon rapid and accurate diagnosis to trigger timely intervention and to inform vaccine strain selection. The development of highly sensitive detection platforms, such as affinity peptide-based electrochemical biosensors capable of detecting as few as 5 copies/mL of the virus [11], and advanced nanoPCR assays using gold nanoparticles for multiplex detection of BRV alongside other enteric pathogens [13], are crucial tools for modern herd health management. Real-time molecular surveillance, enabled by these technologies, allows for the dynamic adjustment of immunoprophylactic approaches, ensuring that vaccines and passive antibody preparations are optimally matched to the prevailing viral threats. The WOAH and the Food and Agriculture Organization (FAO) emphasize that cost-effective control of endemic diseases like rotaviral diarrhea relies on integrated strategies combining biosecurity, surveillance, and targeted immunization, a paradigm that is especially critical given the zoonotic potential of bovine RVA strains and their documented role in the emergence of novel human-pathogenic reassortants [1, 12, 16, 21, 23, 25].

References

[1] Yan N, Li R, Wang Y, Zhang B, Yue H, Tang C. High prevalence and genomic characteristics of G6P[1] Bovine Rotavirus A in yak in China.. Journal of General Virology. 2020. DOI: https://doi.org/10.1099/jgv.0.001426

[2] Odagiri K, Yoshizawa N, Sakihara H, Umeda K, Rahman S, Nguyen SV, et al.. Development of Genotype-Specific Anti-Bovine Rotavirus A Immunoglobulin Yolk Based on a Current Molecular Epidemiological Analysis of Bovine Rotaviruses A Collected in Japan during 2017–2020. Viruses. 2020. DOI: https://doi.org/10.3390/v12121386

[3] Liu X, Yan N, Yue H, Wang Y, Zhang B, Tang C. Detection and molecular characteristics of bovine rotavirus A in dairy calves in China. Journal of Veterinary Sciences. 2021. DOI: https://doi.org/10.4142/jvs.2021.22.e69

[4] Nazaktabar A, Madadgar O. Phylogenetic Study of VP6 Gene of Bovine Rotavirus A and Molecular Survey of Bovine Rotaviruses B and C, and Human G and P Genotypes of Rotavirus A in Calves in Iran. International Journal of Enteric Pathogens. 2020. DOI: https://doi.org/10.34172/IJEP.2020.14

[5] Niu X, Liu Q, Wang P, Zhang G, Jiang L, Zhang S, et al.. Establishment of an Indirect ELISA Method for the Detection of the Bovine Rotavirus VP6 Protein. Animals. 2024. DOI: https://doi.org/10.3390/ani14020271

[6] Hasan M, Kabir M, Miyaoka Y, Yamaguchi M, Takehara K. G and P genotype profiles of rotavirus a field strains circulating in a vaccinated bovine farm as parameters for assessing biosecurity level. Journal of Veterinary Medical Science. 2022. DOI: https://doi.org/10.1292/jvms.22-0026

[7] Brunauer M, Roch F, Conrady B. Prevalence of Worldwide Neonatal Calf Diarrhoea Caused by Bovine Rotavirus in Combination with Bovine Coronavirus, Escherichia coli K99 and Cryptosporidium spp.: A Meta-Analysis. Animals. 2021. DOI: https://doi.org/10.3390/ani11041014

[8] Kim S, Choi Y, Miguel M, Lee S, Lee S, Lee S. Analysis of Fecal Microbial Changes in Young Calves Following Bovine Rotavirus Infection. Veterinary Sciences. 2023. DOI: https://doi.org/10.3390/vetsci10080496

[9] Chen S, Zhang W, Zhai J, Chen X, Qi Y. Prevalence of bovine rotavirus among cattle in mainland China: A meta-analysis.. Microbial Pathogenesis. 2022. DOI: https://doi.org/10.1016/j.micpath.2022.105727

[10] Uddin N, Khair A, Hassan J, Abu MZ, Noor H, Khan A, et al.. Risk factors for bovine rotavirus infection and genotyping of bovine rotavirus in diarrheic calves in Bangladesh. PLoS ONE. 2022. DOI: https://doi.org/10.1371/journal.pone.0264577

[11] Cho CH, Park T, Park JP. Affinity Peptide-based Electrochemical Biosensor for the Highly Sensitive Detection of Bovine Rotavirus. Biotechnology and Bioprocess Engineering. 2022. DOI: https://doi.org/10.1007/s12257-022-0044-6

[12] Moutelíková R, Sauer P, Heroldová MD, Holá V, Prodělalová J. Emergence of Rare Bovine–Human Reassortant DS-1-Like Rotavirus A Strains with G8P[8] Genotype in Human Patients in the Czech Republic. Viruses. 2019. DOI: https://doi.org/10.3390/v11111015

[13] Wang M, Yan Y, Wang R, Wang L, Zhou H, Li Y, et al.. Simultaneous Detection of Bovine Rotavirus, Bovine Parvovirus, and Bovine Viral Diarrhea Virus Using a Gold Nanoparticle-Assisted PCR Assay With a Dual-Priming Oligonucleotide System. Frontiers in Microbiology. 2019. DOI: https://doi.org/10.3389/fmicb.2019.02884

[14] Alfajaro MM, Kim J, Barbé L, Cho E, Park J, Soliman M, et al.. Dual Recognition of Sialic Acid and αGal Epitopes by the VP8* Domains of the Bovine Rotavirus G6P[5] WC3 and of Its Mono-reassortant G4P[5] RotaTeq Vaccine Strains. Journal of Virology. 2019. DOI: https://doi.org/10.1128/JVI.00941-19

[15] Rocha TG, Silva FDF, Gregori F, Alfieri A, Buzinaro MG, Fagliari J. Longitudinal study of bovine rotavirus group A in newborn calves from vaccinated and unvaccinated dairy herds. Tropical Animal Health and Production. 2017. DOI: https://doi.org/10.1007/s11250-017-1263-2

[16] Tacharoenmuang R, Komoto S, Guntapong R, Ide T, Singchai P, Upachai S, et al.. Characterization of a G10P[14] rotavirus strain from a diarrheic child in Thailand: Evidence for bovine-to-human zoonotic transmission.. Infection, Genetics and Evolution. 2018. DOI: https://doi.org/10.1016/j.meegid.2018.05.009

[17] Chen F, Knutson T, Ciarlet M, Sturos M, Marthaler D. Complete genome characterization of a rotavirus B (RVB) strain identified in Alpine goat kids with enteritis reveals inter-species transmission with RVB bovine strains. Journal of General Virology. 2018. DOI: https://doi.org/10.1099/jgv.0.001022

[18] Benito A, Monteagudo L, Arnal JL, Baselga C, Quílez J. Occurrence and genetic diversity of rotavirus A in faeces of diarrheic calves submitted to a veterinary laboratory in Spain.. Preventive Veterinary Medicine. 2020. DOI: https://doi.org/10.1016/j.prevetmed.2020.105196

[19] Collins P, Mulherin E, Cashman O, Lennon G, Gunn L, O’Shea H, et al.. Detection and characterisation of bovine rotavirus in Ireland from 2006–2008. Irish Veterinary Journal. 2014. DOI: https://doi.org/10.1186/2046-0481-67-13

[20] Medeiros TNdS, Lorenzetti E, Alfieri A, Alfieri A. Phylogenetic analysis of a G6P[5] bovine rotavirus strain isolated in a neonatal diarrhea outbreak in a beef cattle herd vaccinated with G6P[1] and G10P[11] genotypes. Archives of Virology. 2014. DOI: https://doi.org/10.1007/s00705-014-2271-4

[21] Tacharoenmuang R, Komoto S, Guntapong R, Ide T, Sinchai P, Upachai S, et al.. Full Genome Characterization of Novel DS-1-Like G8P[8] Rotavirus Strains that Have Emerged in Thailand: Reassortment of Bovine and Human Rotavirus Gene Segments in Emerging DS-1-Like Intergenogroup Reassortant Strains. PLoS ONE. 2016. DOI: https://doi.org/10.1371/journal.pone.0165826

[22] Badaracco A, Garaicoechea L, Matthijnssens J, Uriarte E, Odeón A, Bilbao G, et al.. Phylogenetic analyses of typical bovine rotavirus genotypes G6, G10, P[5] and P[11] circulating in Argentinean beef and dairy herds.. Infection, Genetics and Evolution. 2013. DOI: https://doi.org/10.1016/j.meegid.2013.04.023

[23] Tacharoenmuang R, Komoto S, Guntapong R, Ide T, Haga K, Katayama K, et al.. Whole Genomic Analysis of an Unusual Human G6P[14] Rotavirus Strain Isolated from a Child with Diarrhea in Thailand: Evidence for Bovine-To-Human Interspecies Transmission and Reassortment Events. PLoS ONE. 2015. DOI: https://doi.org/10.1371/journal.pone.0139381

[24] Silva FD, Gregori F, Gonçalves AC, Samara SI, Buzinaro MG. Molecular characterization of group A bovine rotavirus in southeastern and central-western Brazil, 2009-2010. Pesquisa Veterinaria Brasileira. 2012. DOI: https://doi.org/10.1590/S0100-736X2012000300010

[25] Nyaga M, Jere K, Jere K, Esona M, Seheri M, Stucker K, et al.. Whole genome detection of rotavirus mixed infections in human, porcine and bovine samples co-infected with various rotavirus strains collected from sub-Saharan Africa. Infection, Genetics and Evolution. 2015. DOI: https://doi.org/10.1016/j.meegid.2015.02.011

[26] Badaracco A, Garaicoechea L, Rodriguez D, Uriarte E, Odeón A, Bilbao G, et al.. Bovine rotavirus strains circulating in beef and dairy herds in Argentina from 2004 to 2010.. Veterinary Microbiology. 2012. DOI: https://doi.org/10.1016/j.vetmic.2011.12.011

[27] Hu L, Ramani S, Czakó R, Sankaran B, Yu Y, Smith DF, et al.. Structural basis of glycan specificity in neonate-specific bovine-human reassortant rotavirus. Nature Communications. 2015. DOI: https://doi.org/10.1038/ncomms9346

[28] Dennis F, Fujii Y, Haga K, Damanka S, Lartey B, Agbemabiese C, et al.. Identification of Novel Ghanaian G8P[6] Human-Bovine Reassortant Rotavirus Strain by Next Generation Sequencing. PLoS ONE. 2014. DOI: https://doi.org/10.1371/journal.pone.0100699

[29] Ghonaim AH, Hopo MG, Ghonaim NH, Jiang Y, He Q, Li W. The Epidemiology of Circulating Rotavirus Associated with Diarrhea in Egyptian Kids and Calves: A Review. Zoonoses. 2023. DOI: https://doi.org/10.15212/zoonoses-2023-0004

[30] Caruzo TAR, Brito WD, Munford V, Rácz M. Molecular characterization of G and P-types bovine rotavirus strains from Goiás, Brazil: high frequency of mixed P-type infections.. Memórias do Instituto Oswaldo Cruz. 2010. DOI: https://doi.org/10.1590/S0074-02762010000800014

[31] Jeong S, Than VT, Lim I, Kim W. Whole-Genome Analysis of a Rare Human Korean G3P Rotavirus Strain Suggests a Complex Evolutionary Origin Potentially Involving Reassortment Events between Feline and Bovine Rotaviruses. PLoS ONE. 2014. DOI: https://doi.org/10.1371/journal.pone.0097127

[32] Singh S, Singh R, Singh K, Singh V, Malik Y, Kamdi B, et al.. Immunohistochemical and molecular detection of natural cases of bovine rotavirus and coronavirus infection causing enteritis in dairy calves. Microbial Pathogenesis. 2019. DOI: https://doi.org/10.1016/j.micpath.2019.103814

[33] Cui J, Fu X, Xie J, Gao M, Hong M, Chen Y, et al.. Critical role of cellular cholesterol in bovine rotavirus infection. Virology Journal. 2014. DOI: https://doi.org/10.1186/1743-422X-11-98

[34] Rondelli A, Rondelli L, Monteiro BRG, Lorenzetti E, Tineli TR, Dutra V, et al.. Outbreak of neonatal diarrhea caused by multiple genotypes of rotavirus A in a beef calves herd. Pesquisa Veterinária Brasileira. 2018. DOI: https://doi.org/10.1590/1678-5150-PVB-5617

[35] Murtaza N, Nawaz M, Yaqub T, Mehmood AK. Impact of Limosilactobacillus fermentum probiotic treatment on gut microbiota composition in sahiwal calves with rotavirus diarrhea: A 16S metagenomic analysis study”. BMC Microbiology. 2024. DOI: https://doi.org/10.1186/s12866-024-03254-z

[36] Bhandari N, Rongsen-Chandola T, Bavdekar A, John J, Antony K, Taneja S, et al.. Efficacy of a Monovalent Human-Bovine (116E) Rotavirus Vaccine in Indian Infants: A Randomised Double Blind Placebo Controlled Trial. The Lancet. 2014. DOI: https://doi.org/10.1016/S0140-6736(13)62630-6

[37] Bhandari N, Rongsen-Chandola T, Bavdekar A, John J, Antony K, Taneja S, et al.. Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian children in the second year of life.. Vaccine. 2014. DOI: https://doi.org/10.1016/j.vaccine.2014.04.079

[38] Debelo M, Abdela H, Tesfaye A, Tiruneh A, Mekonnen G, Asefa Z, et al.. Prevalence of Bovine Rotavirus and Coronavirus in Neonatal Calves in Dairy Farms of Addis Ababa, Ethiopia: Preliminary Study. BioMed Research International. 2021. DOI: https://doi.org/10.1155/2021/5778455

[39] Yesari E, Özkan TM, Hasan A, Akdeniz I, Burak K, Hatice E. Co-Infection of Bovine Papular Stomatitis Virus, Rotavirus and Cryptosporidium Spp. in a Calf. Acta Veterinaria. 2020. DOI: https://doi.org/10.2478/acve-2020-0039

[40] Praharaj I, Platts-Mills J, Taneja S, Antony K, Yuhas K, Flores J, et al.. Diarrheal Etiology and Impact of Coinfections on Rotavirus Vaccine Efficacy Estimates in a Clinical Trial of a Monovalent Human–Bovine (116E) Oral Rotavirus Vaccine, Rotavac, India. Clinical Infectious Diseases. 2018. DOI: https://doi.org/10.1093/cid/ciy896

[41] Klein D, Kern A, Lapan G, Benetka V, Möstl K, Hassl A, et al.. Evaluation of rapid assays for the detection of bovine coronavirus, rotavirus A and Cryptosporidium parvum in faecal samples of calves. The Veterinary Journal. 2008. DOI: https://doi.org/10.1016/j.tvjl.2008.07.016

[42] Xie Z, Fan Q, Liu J, Pang Y, Deng X, Xie Z, et al.. Reverse transcription loop-mediated isothermal amplification assay for rapid detection of Bovine Rotavirus. BMC Veterinary Research. 2012. DOI: https://doi.org/10.1186/1746-6148-8-133

[43] Tsunemitsu H, Morita D, Takaku H, Nishimori T, Imai K, Saif L. First detection of bovine group B rotavirus in Japan and sequence of its VP7 gene. Archives of Virology. 2014. DOI: https://doi.org/10.1007/s007050050546

[44] Civra A, Altomare A, Francese R, Donalisio M, Aldini G, Lembo D. Colostrum from cows immunized with a veterinary vaccine against bovine rotavirus displays enhanced in vitro anti-human rotavirus activity. Journal of Dairy Science. 2019. DOI: https://doi.org/10.3168/jds.2018-16016

[45] Chang J, Li X, Liu H, Yu L. Ovine rotavirus strain LLR-85-based bovine rotavirus candidate vaccines: Construction, characterization and immunogenicity evaluation. Veterinary Microbiology. 2010. DOI: https://doi.org/10.1016/j.vetmic.2010.04.016